cells atcc crl 3022 hek Search Results


96
LGC Standards crl-3022
Crl 3022, supplied by LGC Standards, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/custom%40crl-3022%4010%2E64898%2F2026%2E05%2E01%2E722320?v=LGC+Standards
Average 96 stars, based on 1 article reviews
crl-3022 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

96
Bio-Techne corporation 3022
3022, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/custom%403022%4010%2E1128%2Fjvi%2E02123-19?v=Bio-Techne+corporation
Average 96 stars, based on 1 article reviews
3022 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

99
ATCC research cell line source s hek293s gntl
Research Cell Line Source S Hek293s Gntl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/pm40670814-405-13-19?v=ATCC
Average 99 stars, based on 1 article reviews
research cell line source s hek293s gntl - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC cell lines sf9 atcc crl 1711 hek293s gnti atcc crl 3022
Cell Lines Sf9 Atcc Crl 1711 Hek293s Gnti Atcc Crl 3022, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/pm38035882-199-22-25?v=ATCC
Average 99 stars, based on 1 article reviews
cell lines sf9 atcc crl 1711 hek293s gnti atcc crl 3022 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC hek293s gnti cells
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Hek293s Gnti Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/bio_rxiv__64898__2026__03__07__710266-81-9-13?v=ATCC
Average 99 stars, based on 1 article reviews
hek293s gnti cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

96
ATCC cells atcc crl 3022 hek
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Cells Atcc Crl 3022 Hek, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/pm38537643-269-52-53?v=ATCC
Average 96 stars, based on 1 article reviews
cells atcc crl 3022 hek - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

90
TSI Incorporated tsi 3022
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Tsi 3022, supplied by TSI Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/10__1080_slash_027868290507222-101-13-5?v=TSI+Incorporated
Average 90 stars, based on 1 article reviews
tsi 3022 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Perstorp Chemicals GmbH capa 3031
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Capa 3031, supplied by Perstorp Chemicals GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/us09902095-210-3-28?v=Perstorp+Chemicals+GmbH
Average 90 stars, based on 1 article reviews
capa 3031 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Perstorp Polyols capa 3022
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Capa 3022, supplied by Perstorp Polyols, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/us10344133-190-0-9?v=Perstorp+Polyols
Average 90 stars, based on 1 article reviews
capa 3022 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
LC Laboratories carfilzomib c-3022
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Carfilzomib C 3022, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/pmc06675406-33-5-2?v=LC+Laboratories
Average 90 stars, based on 1 article reviews
carfilzomib c-3022 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
TSI Incorporated condensation particle counter model 3752/3022
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Condensation Particle Counter Model 3752/3022, supplied by TSI Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/pmc06466204-5-12-14?v=TSI+Incorporated
Average 90 stars, based on 1 article reviews
condensation particle counter model 3752/3022 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Pharmacia Upjohn LLC upjohn uc2374 3022 3022a
a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of <t>HEK293S</t> GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.
Upjohn Uc2374 3022 3022a, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cells+atcc+crl+3022+hek/pmc08788739__kuab035_supplemental_file-57-1-7?v=Pharmacia+Upjohn+LLC
Average 90 stars, based on 1 article reviews
upjohn uc2374 3022 3022a - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of HEK293S GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.

Journal: bioRxiv

Article Title: An improved workflow for rapid, large-scale protein production in HEK293 cells via antibiotic enrichment after lentiviral transduction

doi: 10.64898/2026.03.07.710266

Figure Lengend Snippet: a , Vector architecture of pHR-AB-CMV-TetO 2 (Puro R variant). The CMV-MIE promoter drives GOI expression, whereas a compact EF-1 α promoter independently drives expression of the antibiotic-resistance cassette to enable stringent enrichment of transduced cells before induction. All genetic elements are flanked by unique restriction sites. b , Antibiotic variants of the pHR-AB-CMV-TetO 2 system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. c , Inducible expression mechanism of the pHR-AB-CMV-TetO 2 vectors. In TetR-expressing cell lines, TetR binds the two TetO sites and represses the CMV-MIE promoter; addition of doxycycline (Dox) releases TetR and activates GOI transcription. In cell lines lacking TetR, CMV-MIE functions as a strong constitutive promoter. d , Vector architecture of pHR-AIO-AB (Puro R variant). A compact EF-1 α promoter constitutively drives expression of the bicistronic open reading frame encoding rtTA-V16 and the antibiotic-resistance marker linked by a T2A peptide, providing both the transactivator and selection marker from a single transcript. The GOI is placed under the TRE3GS promoter for Dox-inducible expression. All genetic elements are flanked by unique restriction sites. e , Antibiotic variants of the pHR-AIO-AB system, available with puromycin, blasticidin, hygromycin or zeocin cassettes, permitting single-vector selection or orthogonal co-selection when co-infecting with multiple constructs. f , Inducible expression mechanism of the pHR-AIO-AB vectors. In the presence of Dox, rtTA-V16 binds TRE3GS to activate GOI transcription; in the absence of Dox, TRE3GS exhibits very low basal activity, enabling tight control of induction. g , Schematic overview of inducible expression after proviral integration (Puro R variant). Left: The pHR-AB-CMV-TetO 2 proviral DNA is integrated in the genome of HEK293S GnTI − TetR LENTI or HEK293T TetR LENTI cell lines constitutively expressing TetR (from a previously integrated proviral TetR–Blast R cassette). TetR represses the CMV-MIE promoter until Dox is added, which releases repression and triggers GOI transcription. Constitutive expression of the EF-1 α cassette enables antibiotic selection. Right: In regular HEK293S GnTI − or HEK293T cells transduced with pHR-AIO-AB vectors, the EF-1 α cassette constitutively produces rtTA-V16 and the antibiotic-resistance marker, enabling enrichment of transduced cells and subsequent Dox-dependent induction of the GOI. Abbreviations: TKpA, thymidine kinase polyadenylation signal; CTE, constitutive transport element; Puro R , puromycin resistance; EF-1 α , Human elongation factor-1 alpha promoter; cHS4, chicken hypersensitive site 4 insulator; CMV-MIE, human cytomegalovirus major immediate-early promoter; TetO 2 , two tandem Tet (tetracycline) operator sites; GOI, gene of interest; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; Zeo R , zeocin resistance; Hygro R , hygromycin resistance; Blast R , blasticidin resistance; TetR, Tet Repressor protein; Dox, doxycycline; T2A, Thosea asigna virus 2A peptide; c-myc NLS, nuclear localisation signal derived from the c-Myc protein; rtTA V16, reverse tetracycline transactivator V16; TRE3GS, minimal CMV promoter with seven TetO operator sequences; HEK293, human embryonic kidney 293; GnTI − , N-acetylglucosaminyltransferase I-deficient; dsDNA, double-stranded DNA.

Article Snippet: HEK293T cells (G418 R ; ATCC, cat. no. CRL-3216) HEK293S GnTI − cells (ATCC, cat. no. CRL-3022) HEK293T TetR LENTI cells (G418 R , Blast R ; obtainable by request to J.E.)

Techniques: Plasmid Preparation, Variant Assay, Expressing, Selection, Construct, Marker, Activity Assay, Control, Transduction, Virus, Derivative Assay

a , HEK293T benchmark. Cells were infected at low MOI to yield a ∼5–15% mNG–positive cell pool before selection. Flow cytometry histograms show enrichment of the sparsely infected populations to >90% mNG-positive with a tight, unimodal distribution. Because HEK293T cells lack TetR, CMV-MIE-TetO 2 drives constitutive expression. The magenta line marks the positivity threshold used for gating. b , HEK293S GnTI⁻ TetR benchmark. Low-MOI infection produced a ∼5 % mNG-positive cell pool that increased to >90% after two selection cycles. In the TetR background, basal expression in the enriched population was low-leak (∼1–5% positive without Dox); addition of Dox (1 µg/mL) produced a uniform and robust right-shift, indicating tight repression and synchronous induction. Gating as in (a). Abbreviations: AB, antibiotic; CMV, human cytomegalovirus; TetO₂, tandem Tet (tetracycline) operator sites; HEK293, human embryonic kidney 293; mNG, mNeonGreen; GnTI − , N-acetylglucosaminyltransferase I-deficient; TetR, Tet (tetracycline) Repressor protein; BlastR, blasticidin resistance; MOI, multiplicity of infection; Dox, doxycycline.

Journal: bioRxiv

Article Title: An improved workflow for rapid, large-scale protein production in HEK293 cells via antibiotic enrichment after lentiviral transduction

doi: 10.64898/2026.03.07.710266

Figure Lengend Snippet: a , HEK293T benchmark. Cells were infected at low MOI to yield a ∼5–15% mNG–positive cell pool before selection. Flow cytometry histograms show enrichment of the sparsely infected populations to >90% mNG-positive with a tight, unimodal distribution. Because HEK293T cells lack TetR, CMV-MIE-TetO 2 drives constitutive expression. The magenta line marks the positivity threshold used for gating. b , HEK293S GnTI⁻ TetR benchmark. Low-MOI infection produced a ∼5 % mNG-positive cell pool that increased to >90% after two selection cycles. In the TetR background, basal expression in the enriched population was low-leak (∼1–5% positive without Dox); addition of Dox (1 µg/mL) produced a uniform and robust right-shift, indicating tight repression and synchronous induction. Gating as in (a). Abbreviations: AB, antibiotic; CMV, human cytomegalovirus; TetO₂, tandem Tet (tetracycline) operator sites; HEK293, human embryonic kidney 293; mNG, mNeonGreen; GnTI − , N-acetylglucosaminyltransferase I-deficient; TetR, Tet (tetracycline) Repressor protein; BlastR, blasticidin resistance; MOI, multiplicity of infection; Dox, doxycycline.

Article Snippet: HEK293T cells (G418 R ; ATCC, cat. no. CRL-3216) HEK293S GnTI − cells (ATCC, cat. no. CRL-3022) HEK293T TetR LENTI cells (G418 R , Blast R ; obtainable by request to J.E.)

Techniques: Infection, Selection, Flow Cytometry, Expressing, Produced